Regulus Therapeutics
RGLS
#7355
Rank
HK$4.43 B
Marketcap
HK$64.03
Share price
0.00%
Change (1 day)
441.38%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of March 2025 : HK$0.51 Billion

According to Regulus Therapeutics's latest financial reports the company has HK$0.51 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$0.58 B216.93%
2023-12-31HK$0.18 B-39.33%
2022-12-31HK$0.30 B-35.02%
2021-12-31HK$0.47 B95.38%
2020-12-31HK$0.24 B-9.31%
2019-12-31HK$0.26 B143.52%
2018-12-31HK$0.10 B-76.75%
2017-12-31HK$0.46 B-20.48%
2016-12-31HK$0.59 B-33.24%
2015-12-31HK$0.88 B-28.65%
2014-12-31HK$1.23 B40.16%
2013-12-31HK$0.88 B16.26%
2012-12-31HK$0.76 B156.66%
2011-12-31HK$0.29 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Sanofi
SNY
HK$56.86 B 10,987.15%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$10.08 B 1,865.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$86.83 B 16,830.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$38.98 B 7,500.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$32.29 B 6,196.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
HK$0.21 B-57.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$25.95 B 4,960.81%๐Ÿ‡บ๐Ÿ‡ธ USA